ArticleAdvanced healthcare materials2026
Highly Tunable and Cell-Remodelable Thiol-ene Alginate-Peptide Crosslinked Hydrogels to Recreate Cellular and Organoid Microenvironments for Biofabrication.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Thiolated Polymers in 3D Bioprinting: Control of Gelation.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Intelligent design and application of molecular recognition hydrogels in tissue engineering.Materials today. Bio · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In this study, a cell-mediated degradable alginate hydrogel system for organoid culture and amenable to biofabrication technologies is presented. Norbornene-functionalized alginate is crosslinked with a di-thiolated peptide sequence cleavable by matrix metalloproteinases and decorated with cysteine-terminated cell-adhesion peptide RGD, upon exposure to UV. Stiffness of the hydrogels can be controlled by tuning polymer and crosslinker concentrations. Pre-gel solutions are successfully bioprinted with a pneumatic extrusion-based system. The hydrogels are used to encapsulate a variety of sensitive cell types. Human endometrial organoids present high cell viability, grow in size over time, present spherical morphology, and express cell-cell contacts E-cadherin and proliferation marker Ki67. Encapsulated mouse embryonic stem cell-derived thyroid follicles produce thyroglobulin and T4. Mouse intestinal organoids adopt a proliferative phenotype. Vascularization inside the hydrogels is achieved using endothelial cells and supporting cells (single cell suspension and spheroids). Neurite outgrowth, both small and thick bundles, from encapsulated iPSC-derived neurospheres, demonstrates the reinnervation potential of the hydrogel. This polysaccharide hydrogel platform could be used as a defined, tunable, and ethical alternative to mouse sarcoma-extracted basement-membrane matrices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.